Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 441 of 6351
-
New pill could offer hope for younger breast cancer patients
Disease control Recruiting nowThis study will include two groups of patients: Cohort 1 and Cohort 2. Cohort 1: will help researchers learn how a medicine called imlunestrant (LY3484356) affects a specific type of breast cancer. Some patients will take both imlunestrant and another treatment to suppress their…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for tough pancreatic cancer: targeted drug combo under study
Disease control Recruiting nowThis phase III trial compares the effect of adding panitumumab to standard chemotherapy (with nanoliposomal Irinotecan, leucovorin, and 5-fluorouracil \[5-FU\] or irinotecan, leucovorin, and 5-FU or nab-paclitaxel and gemcitabine) versus standard chemotherapy alone in treating pa…
Phase 3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New device aims to catch debris during heart procedure, reduce stroke risk
Disease control Recruiting nowThe objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus/debris during self-expanding transcatheter aortic valve replacement (TAVR) procedures.
Sponsor: EmStop Inc • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Light therapy may speed healing of diabetic foot ulcers, trial asks
Disease control Recruiting nowFoot ulcers in people with diabetes mellitus represent one of the most serious chronic complications of the disease, being associated with persistent inflammation, high oxidative stress, microvascular dysfunction and systemic hemorheological changes that compromise the progressio…
Phase 2 • Sponsor: University of Nove de Julho • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Engineered donor cells take aim at tough T-Cell cancers
Disease control Recruiting nowPatients eligible for this study have a type of blood cancer called T-cell leukemia or lymphoma (lymph gland cancer). The body has different ways of fighting infection and disease. This study combines two different ways of fighting disease with antibodies and T cells. Antibodies…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Brain tumor virus therapy tested in kids and young adults
Disease control Recruiting nowThe goal of this clinical trial is to learn if intratumoral administration of DNX-2401 works to treat recurrent and refractory high grade brain tumors in children and young adults. It will also learn about the safety of DNX-2401. The main questions it aims to answer are: * Does…
Phase 2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to improve First-Line colorectal cancer treatment
Disease control Recruiting nowThis is a Phase Ⅱ/Ⅲ study. The purpose of this study is to evaluate the efficacy and safety of RC148 combined with chemotherapy for the first-line treatment of unresectable metastatic colorectal cancer (CRC)
Phase 2/3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New needle treatment could zap pancreatic cysts before they turn cancerous
Disease control Recruiting nowThis phase II trial tests the effect of endoscopic ultrasound (EUS)-guided chemoablation in treating patients with pancreatic cysts. Pancreatic cancer is a fatal disease that is difficult to diagnose at an early stage, and the five-year survival rate is currently less than 10%. P…
Phase 2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo aims to keep early lung cancer from coming back
Disease control Recruiting nowThe researchers are doing this study to find out whether ivonescimab after receiving standard stereotactic body radiotherapy (SBRT) is an effective treatment in people with Non-Small Cell Lung Cancer (NSCLC).
Phase 1/2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New eczema cream shows promise in major trial
Disease control Recruiting nowA multicenter, randomized, double-blind, vehicle controlled phase III clinical study to evaluate the efficacy and safety of VC005 in adults and adolescents with mild to moderate atopic dermatitis
Phase 3 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Smart sensors could predict falls in older adults with dizziness
Knowledge-focused By invitation onlyFalls can be serious for older people, sometimes even leading to trips to the hospital. It's important to find ways to help prevent falls, especially for older people. Doctors have different tests they use to figure out who might be more likely to fall. One test they use is calle…
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New pump could make dialysis access easier for kidney patients
Disease control Recruiting nowThe AMPLIFI-1 Study is a prospective, multicenter pivotal clinical trial designed to evaluate the safety and effectiveness of the Amplifi™ Vein Dilation System in patients requiring distal arteriovenous fistula (AVF) creation for hemodialysis. The study has two cohorts: a randomi…
Sponsor: Amplifi Vascular, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug aims to stop Alzheimer's before it starts in gene carriers
Prevention Recruiting nowPrimary Objectives: To demonstrate that HT-4253 improves the amyloid risk profile by transitioning biomarker-positive APOE4 carriers from a positive, high risk APS2 score to a negative, low risk APS2 score. Secondary Objectives: * To assess the effects of HT-4253 on tau relate…
Phase 2 • Sponsor: Halia Therapeutics, Inc. • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
Specialty care after cardiac arrest: a lifesaving shift?
Disease control Recruiting nowThis randomized clinical trial will determine if adult participants who are in the emergency department after being resuscitated from a cardiac arrest outside of the hospital benefit from care delivered at specialized centers. The main question that it will answer is whether tra…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New pill could cut heart failure deaths when given early in hospital
Disease control Recruiting nowFACILITATE-HF is a multicenter, randomized, double-blind, placebo-controlled trial designed to determine whether initiation of finerenone during the early phase of hospitalization has beneficial effects in patients with AHF who have left ventricular ejection fraction 40% or more.
Phase 4 • Sponsor: Juntendo University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a lawyer reduce gun violence? trial adds legal aid to trauma recovery
Disease control Recruiting nowHospital-Based Violence Intervention Programs (HVIPs) affiliated with U.S. trauma centers often focus on individual behavior modification to reduce re-victimization. There is a lack of reproducible evidence that has demonstrated effectiveness, given the exclusion of addressing so…
Sponsor: University of Chicago • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New lung-saving strategy aims to cut deadly ARDS complications
Disease control Not yet recruitingAcute respiratory distress syndrome (ARDS) accounts for approximately 10% of all ICU admissions and 23% of patients requiring mechanical ventilation (MV). Despite advances in care, hospital mortality remains high, ranging from 34% in mild cases to 46% in severe ARDS. Positive-pre…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for advanced GIST: experimental drug NB003 takes on resistant tumors
Disease control Recruiting nowNB003-04 is a phase II/III, multicenter, open-label clinical study designed to evaluate the efficacy, safety, and pharmacokinetic (PK) profile of NB003 in patients with gastrointestinal stromal tumors aged 18 years and above (or the legal adult age of consent per local regulation…
Phase 2/3 • Sponsor: Ningbo Newbay Technology Development Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New RSV vaccine trial targets High-Risk adults in japan
Vaccine Recruiting nowThe purpose of the study is to learn about the immune response after a RSVpreF vaccination. This study is being conducted in Japan. RSV is a common virus that can cause infections of the lungs and airways. The study is seeking participants who are: * 18 to 59 years of age * adu…
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
Can a simple CT scan catch lung cancer before It's too late?
Diagnosis Recruiting nowThe main objective is to estimate the detection rate of lung cancer in the population screened by low-dose chest CT scans.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC